Second-line drug resistance markers as proxy indicators of time to sputum culture conversion among second-line drug resistant tuberculosis patients tested in Uganda: A cross-sectional study
-
Published:2023-01-16
Issue:
Volume:12
Page:62
-
ISSN:2046-1402
-
Container-title:F1000Research
-
language:en
-
Short-container-title:F1000Res
Author:
Mujuni DennisORCID,
Ssengooba WillyORCID,
Ibanda Ivan,
Kabugo Joel Solomon,
Kasemire Dianah Linda,
Nampewo Elizabeth,
Nsawotebba Andrew,
Phelan Jody E,
Tugumisirize Didas,
Orena Beatrice,
Byabajungu Henry,
Ntenkaire NathanORCID,
Nadunga Diana,
Tumwine Julius,
Musisi Kenneth,
Joloba Moses,
Kim Seungmo,
Kokas Ikwap,
Mukani William Olaho,
Kungu Joseph,
Afayoa Mathias
Abstract
Background Increased tuberculosis disease burden arises as a result of low treatment success rates stemming from the emergence of second-line drug resistance. We aimed at determining the usefulness of second-line drug (SLD) resistance markers as proxy indicators of time to sputum culture conversion; a renowned predictor of Tuberculosis treatment outcome, among SLD-resistant tuberculosis (TB) patients tested at the Uganda National TB Reference Laboratory (NTRL). Methods A cross-sectional study was conducted on 72 bacteriologically confirmed SLD resistant TB patients with datasets including culture conversion time and second line probe assay mutation profiles between 01/06/2017 and 31/12/2019. The data were then imported into STATA v15 for descriptive statistical analysis, Univariate cox proportional hazard model analysis and Kaplan-Meier survival curves at a 5% level of significance; p-value ≤0.05. Results Results indicate the median time was achieved at 3 (0–12) months across the studied patients. The rrs G1484T mutation associated with conferring drug resistance to injectable agents was observed to have the shortest median conversion time of 1.5 months, longest by the gryB E540D at 5 months. A single mutation in the gryA gene locus showed higher converted proportions 70.8% (58.9–81.0) than those that had two 8.3% (3.1–17.3) or three 2.7% (0.3–10.0) mutations. Conclusions The studied second-line drug resistance markers had no statistically significant association with the time to sputum culture conversion, although increased drug resistance levels reduced the converted proportions and stressed the need to utilize molecular diagnostics data and other crucial variables to better comprehend proxy indicators of SLD resistant tuberculosis management.
Publisher
F1000 Research Ltd
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference45 articles.
1. Global TB Report 2019.,cited 3 Feb 2021
2. Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug Resistance.;J Cegielski;Clin. Infect. Dis.,2016
3. Global TB Report 2020.,cited 3 Nov 2021
4. Global Tuberculosis Report 2017.,cited 3 Feb 2021
5. Global TB Report 2018.,Sep 2018 cited 3 Feb 2021